摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1S,13S,15S,16S)-16-chloro-15-methoxy-5,7-dioxa-12-azapentacyclo[10.6.1.02,10.04,8.013,18]nonadeca-2,4(8),9,17-tetraene | 1138334-50-5

中文名称
——
中文别名
——
英文名称
(1S,13S,15S,16S)-16-chloro-15-methoxy-5,7-dioxa-12-azapentacyclo[10.6.1.02,10.04,8.013,18]nonadeca-2,4(8),9,17-tetraene
英文别名
——
(1S,13S,15S,16S)-16-chloro-15-methoxy-5,7-dioxa-12-azapentacyclo[10.6.1.02,10.04,8.013,18]nonadeca-2,4(8),9,17-tetraene化学式
CAS
1138334-50-5
化学式
C17H18ClNO3
mdl
——
分子量
319.788
InChiKey
XUWWIIBGXFQMPN-AJNGGQMLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    22
  • 可旋转键数:
    1
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    30.9
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (1S,13S,15S,16S)-16-chloro-15-methoxy-5,7-dioxa-12-azapentacyclo[10.6.1.02,10.04,8.013,18]nonadeca-2,4(8),9,17-tetraene 在 indium(III) triflate 、 N-碘代丁二酰亚胺 作用下, 以 乙腈 为溶剂, 反应 12.0h, 以55%的产率得到(1R,13S,15S,16S)-16-chloro-3,9-diiodo-15-methoxy-5,7-dioxa-12-azapentacyclo[10.6.1.02,10.04,8.013,18]nonadeca-2(10),3,8,17-tetraene
    参考文献:
    名称:
    Synthetic analogues of the montanine-type alkaloids with activity against apoptosis-resistant cancer cells
    摘要:
    In a search of small molecules active against apoptosis-resistant cancer cells, a skeletal rearrangement of alkaloid haemanthamine was utilized to generate a series of compounds possessing the alkaloid montanine ring system. The synthesized compounds were found to inhibit proliferation of cancer cells resistant to apoptosis at micromolar concentrations. Selected compounds were also active against patient-derived glioblastoma cells expressing stem-cell markers. This is the first report describing the preparation of synthetic analogues of the montanine-type alkaloids with antiproliferative activity. The compounds prepared in the current investigation appear to be a useful starting point for the development of agents to fight cancers with apoptosis resistance, and thus, associated with poor prognoses. (C) 2018 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2018.01.041
  • 作为产物:
    描述:
    haemanthamine甲基磺酰氯三乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 48.0h, 以55%的产率得到(1S,13S,15S,16S)-16-chloro-15-methoxy-5,7-dioxa-12-azapentacyclo[10.6.1.02,10.04,8.013,18]nonadeca-2,4(8),9,17-tetraene
    参考文献:
    名称:
    Synthetic analogues of the montanine-type alkaloids with activity against apoptosis-resistant cancer cells
    摘要:
    In a search of small molecules active against apoptosis-resistant cancer cells, a skeletal rearrangement of alkaloid haemanthamine was utilized to generate a series of compounds possessing the alkaloid montanine ring system. The synthesized compounds were found to inhibit proliferation of cancer cells resistant to apoptosis at micromolar concentrations. Selected compounds were also active against patient-derived glioblastoma cells expressing stem-cell markers. This is the first report describing the preparation of synthetic analogues of the montanine-type alkaloids with antiproliferative activity. The compounds prepared in the current investigation appear to be a useful starting point for the development of agents to fight cancers with apoptosis resistance, and thus, associated with poor prognoses. (C) 2018 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2018.01.041
点击查看最新优质反应信息

文献信息

  • Antiproliferative and Structure Activity Relationships of Amaryllidaceae Alkaloids
    作者:Juan Cedrón、Ángel Ravelo、Leticia León、José Padrón、Ana Estévez-Braun
    DOI:10.3390/molecules200813854
    日期:——
    The antiproliferative activity of a set of seven natural Amaryllidaceae alkaloids and 32 derivatives against four cancer cell lines (A2780, SW1573, T47-D and WiDr) was determined. The best antiproliferative activities were achieved with alkaloids derived from pancracine (2), haemanthamine (6) and haemantidine (7). For each skeleton, some structure-activity relationships were outlined.
    确定了一组七种天然金莲花科生物碱和32种衍生物对四种癌细胞系(A2780,SW1573,T47-D和WiDr)的抗增殖活性。源自潘克拉辛(2),血红花胺(6)和雷曼替丁(7)的生物碱具有最佳的抗增殖活性。对于每个骨架,概述了一些构效关系。
  • Bioactive Montanine Derivatives from Halide-induced Rearrangements of Haemanthamine-type Alkaloids. Absolute Configuration by VCD
    作者:Juan C. Cedrón、Ana Estévez-Braun、Ángel G. Ravelo、David Gutiérrez、Ninoska Flores、María A. Bucio、Nury Pérez-Hernández、Pedro Joseph-Nathan
    DOI:10.1021/ol900065x
    日期:2009.4.2
    An unexpected rearrangement of haemanthamine-type alkaloids in the presence of halogenating agents has been found. Rearranged compounds present the 5,11-methanomorphantridine framework characteristic of montanine-type alkaloids. These compounds are difficult to obtain because of their scarcity in natural sources and because the synthetic approaches developed so far require numerous steps. Vibrational circular dichroism (VCD) spectroscopy was used to determine the absolute configuration of one of the rearranged compounds. Several rearranged alkaloids showed antimalarial activity.
  • Synthetic analogues of the montanine-type alkaloids with activity against apoptosis-resistant cancer cells
    作者:Karthik Govindaraju、Aude Ingels、Md Nabiul Hasan、Dandan Sun、Veronique Mathieu、Marco Masi、Antonio Evidente、Alexander Kornienko
    DOI:10.1016/j.bmcl.2018.01.041
    日期:2018.2
    In a search of small molecules active against apoptosis-resistant cancer cells, a skeletal rearrangement of alkaloid haemanthamine was utilized to generate a series of compounds possessing the alkaloid montanine ring system. The synthesized compounds were found to inhibit proliferation of cancer cells resistant to apoptosis at micromolar concentrations. Selected compounds were also active against patient-derived glioblastoma cells expressing stem-cell markers. This is the first report describing the preparation of synthetic analogues of the montanine-type alkaloids with antiproliferative activity. The compounds prepared in the current investigation appear to be a useful starting point for the development of agents to fight cancers with apoptosis resistance, and thus, associated with poor prognoses. (C) 2018 Elsevier Ltd. All rights reserved.
查看更多